| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |